Hypertension and the Problem of Vascular Homeostasis
By IRVINE H. PAGE AND A. C. CORCORAN FIFTY YEARS ago hypertension was not a clinical problem. When it was thought of at all, it seemed to be a providential compensation for diffuse structural narrowing and rigidity of small vessels due to "arteriocapillary fibrosis." The incidence and magnitude of the problem began to be appreciated only some thirty years ago when it was generally recognized that hypertension could be discovered in people whose small vessels and circulation generally were structurally intact. Essential hypertension was defined as a clinical entity. By definition, it had no cause, or was "constitutional," so that none but the very enthusiastic or faintly dishonest discussed the possibility of either understanding or curing it. Research was sporadic and speculative. Animal experiments dealt only with acute changes in arterial pressure. Clinical hypertensive disease had no experimental analogue.
This discouraging state changed some twenty years ago when two forms of experimental hypertension were established in animals. The one was neurogenic and resulted from section of the sino-aortic depressor nerves. The other was renal and was elicited by partial compression of the renal artery, or, more recently, by perinephritis." 2 Hypertensive disease has also been produced in rats by administration of desoxycorticosterone and sodium salts, of crude pituitary powder and of growth hormone.3 The development of means of sustaining life after nephrectomy has resulted in convincing demon-From the Research Division of the Cleveland Clinic Foundation, and the Frank E. Bunts Educational Institute, Cleveland, Ohio. 286 strations of postnephrectomy hypertension in dogs and rats. A neurogenic hypertension has also been obtained by repetitive irritation of the floor of the fourth ventricle. Thus, the experimentalist has been provided with means of studying neurogenic, renal and endocrine mechanisms in hypertension.
The availability of these experimental diseases intensified research into causes and mechanisms, and has led to an analysis of cases of clinical hypertension which is much less perfunctory than the custom was a few years ago. The discovery of hypertension of ascertainable origin and remediable nature has saved the lives of some hundreds of patients. But the problem extends to the millions. In the overwhelming majority of cases, hypertension is still essential and its treatment in a large degree expectant, symptomatic and, in a word, unsatisfactory. So many facts have now accumulated in the research pool certainly too many to be considered in any detailthat it is at least opportune from time to time to arrange some of them into patterns which point to pathways which seem to promise most in the research of the future. Such is the aim of this report.
The basic mechanism of essential hypertension is an increase in arteriolar resistance, coupled with an increase in the force of the heart's beat. Associated phenomena in uncomplicated cases are maintenance of cardiac output and peripheral blood flow at approximately normal levels. The problem centers on those factors which directly or indirectly affect arteriolar resistance and, especially, those which Circulation, Vnoluwe IVI, August 1952 increase it. These can be grouped as (a) vasomotor, (b) humoral, and (c) possibly also intrinsic changes in the smooth muscle of the arterioles. Since these last have not been seriously studied, however, the discussion must center on the former two categories.
(A) VASOMOTOR MECHANISMS The several areas in the brain and brain stem at which appropriate stimulation results in changes in arterial pressure and the caliber of arterioles, of which the best defined is the medullary center, are probably more accurately described as aggregates of cells with direct vasomotor outflow than as discrete centers. There is certainly a very widespread distribution of cells which can influence vasomotor function; the centers themselves are functionally interdependent and responsive also to a variety of other controls, from the cortex and thalamus, from respiratory centers, from central and peripheral chemo-and baroreceptors and from substances which reach them in the blood.4
The major pathways of pressor and vasoconstrictor discharge from the cerebral pressor centers leads through the cells of the lateral horn of the cord, the dorsolumbar and peripheral sympathetic ganglia to sympathetic vasomotor neurons and the adrenal medulla. Passage of impulses through the ganglia seems to be accomplished by release of acetylcholine around the terminal neuron. Ganglionic transmission is therefore damped or abolished by substances which, like tetraethylammonium (TEAC) seem to compete with acetylcholine at this point. Peripherally, the discharge is apparently accomplished by release around cells in the vessel wall or into adrenal venous blood of a mixture of adrenaline and noradrenaline.5
Whereas adrenaline is the major component of normal adrenal medullary secretion, the material released at vasomotor nerve endings is probably in larger measure noradrenaline. This varying proportion in the distribution of adrenergic neurohumors accords teleologically with the fact that noradrenaline is a more consistent vasoconstrictor substance than adrenaline, while adrenaline has more powerful specific metabolic effects. Thus, adrenaline, which is the methylated derivative of norad-renaline, has more effect on heart muscle, so that tachycardia and palpitation characterize its action. Inl appropriate dilutions and in some areas, such as skeletal muscles, it can be a vasodilator, which apparently noradrenaline cannot be. Adrenaline is also more glycogenolytic and a more potent stimulus of metabolic rate and ACTH release. Pharmacologically, it is the more susceptible to adrenergic blocking agents, such as the benzodioxanes, chlorethylamine and imidazoline derivatives. Hemodynamically, small doses of adrenaline increase cardiac output and may decrease over-all peripheral resistance, although regionally, as in the kidney it usually increases peripheral resistance by causing arteriolar constriction. Equipressor doses of noradrenaline consistently increase both total peripheral and regional resistance. The functional pattern noradrenaline induces is more like that of essential hypertension than that caused by adrenaline; this characteristic has been suggested as a partial explanation of the syndrome which results from the presence of pheochromocytomas, the secretion of which is principally composed of noradrenaline.
As far as essential hypertension is concerned, a corollary of the hemodynamic properties of noradrenaline is that sympathetic vasomotor participation in its mechanism and maintenance must be more seriously considered than that of adrenaline and that thought be given to the possibilities and results of its central inhibition or peripheral blockade. The demonstration, in other fields of study of nervous function, that reverberating arcs may sustain a discharge, as in causalgia or the sympathetic neurovascular dystrophies, suggests that the functioning of afferent pathways should be brought into question as well, for these have not been sufficiently explored.
On the efferent side, the assumption that increased vasomotor discharge is a fundamental mechanism in essential hypertension has underlain the surgical treatment of this condition of adrenal denervation, dorsal and dorsolumbar and total sympathectomies and the more recent studies of the actions and uses of agents which cause peripheral blockade, either ganglionic -(TEAC, hexamethonium) or adrenergic. The transient and, in the case of the operations, sometimes lasting decreases of pressure thus obtained have been advanced as evidence that essential hypertension is caused by increased vasomotor discharge. But the effects are far from uniform, the argument is one more of analogy than proof and it neglects the possibility that all that may have been done was to remove a normally functioning mechanism from the group of the normal and abnormal mechanisms which combine to maintain arterial pressure.
Among the vasomotor afferents, the sinoaortic buffer system is of much more interest now than it was when experimental chronic neurogenic hypertension was produced in animals by its resection. At that time, lack of interest was conditioned by the facts that (a) hypertensive patients apparently respond normally to pressure over the carotid sinus and (b) the technic of eliciting experimental neurogenic hypertension was uncertain and the mortality sometimes excessive, while (c) the hypertension was attributed principally to an increased cardiac output, which at once differentiates it from clinical essential hypertension. But it must be recognized that carotid pressure is not an adequate test of the delicately balanced function of the sino-aortic receptors and as far as the experimental disease is concerned, the cardiac factor is apparently less significant than the increase in peripheral resistance. The fact that total sympathectomy reduces the blood pressure of these animals to normal indicates that the pressure was sustained by increased vasomotor discharge. Another indication of this is the resistance of these animals to blockade of the sympathetic ganglia by TEAC.A This resistance may be attributed to excessive liberation of acetylcholine in the gan glia consequent to the unchecked discharge of the vasomotor center; whatever its cause, the phenomenon demonstrates that abnormal activity of the sino-aortic system is reflected in abnormalities of ganglionic function.
Clinically, estimates of ganglionic resistance to TEAC blockade may serve as a means of selecting patients whose hypertension is associated with excessive vasomotor discharge. Preliminary observations indicate that in-creased resistance is demonstrable in a minority of patients with essential hypertension. Further study may confirm the assumption that this finding earmarks the hypertension as one predominantly neurogenic, which should, therefore, respond favorably and uniformly to adequate surgical sympathectomy. But the sino-aortic is by no means the only afferent pathway which may participate in abnormal vasomotor regulation. Another, which arises in receptors principally in the myocardium and also in the lung, is the von Bezold reflex system. Stimulation of this system accounts in some measure for the decrease in arterial pressure and peripheral resistance which characterizes the action of veratrum alkaloids and, parenthetically, may participate in the prolonged decreases of arterial pressure which sometimes follow myocardial infarction.
There is some evidence to suggest that afferents which pass through posterior root ganglia have obscure but powerful central vasomotor influence. Intracranial receptors which respond to vasoactive agents in the sense of correcting or opposing their normal peripheral vascular actions have recently been described.7 These and the extramedullary centers of vasomotor regulation are all but unexplored. The probable rewards from the advanced study of these mechanisms are indicated by the acknowledged influences of the psyche on arterial pressure and on the course of hypertensive disease. Indeed, the phenomenon of the "hypertensive diencephalic syndrome" is a cogent experiment on Nature's part which seems directly to relate abnormal central nervous function to one form of essential hypertension. Lastly, vasomotor control of arterial pressure must be thought of not only in terms of stimuli which directly change the caliber of the vessels, but also in terms of changes in the capacity of the vessel to respond to standard stimuli and of the effect of nervous influences on vascular reactivity. A familiar example of such a mechanism is the hypersensitivity of vessels which have been deprived of their innervation.8 Less familiar is the increase in reactivity which follows functional ganglionic blockade, surgical ganglionectomy and section of the spinal cord. Clinically, the latter hyper-sensitivity is reflected in the paroxysms of hypertension sometimes seen in paraplegias and attributed to release of adrenal medullary secretion. The reverse phenomenon, refractoriness instead of hyperreactivity, is seen in animals exposed to high carbon dioxide concentrations; their vessels become refractory to normal stimuli, not because of paralysis or anesthesia, but because impulses are abnormally transmitted from the sympathetic ganglia; sympathectomy or ganglionic blockade restores this lost vascular reactivity.9 Thus the normal influence of vasomotor nerves on vascular reactivity is in part one of moderating their response to stimulation. An excess of this influence results in refractoriness and deprivation of it in hyperresponsiveness.
In summary, closer analysis of the participation of the nervous system in the control of arterial pressure and peripheral resistance provides pathways of fertile study. This should be concerned not only with the activity of the efferent vasomotor system in essential hypertension, but, possibly with greater prospect of reward, in an unravelling of afferent pathways and their receptor mechanisms and of the influence and controls of the vasomotor centers.
Unfortunately, neurophysiologic research as it was practised by such pioneers as Sherrington and Bayliss is almost in abeyance. The von Eulers, Heymans, Liljestrands and Folkows, and those like them who now return to these methods and supplement them with modern methodology, will certainly resolve some part of the riddle of neurovascular function in essential hypertension.
(B) HUMORAL MECHANISMS
The humoral factors which may contribute to the genesis or participate in the maintenance of essential hypertension can be grouped as (1) endocrine, (2) renal, (3) hepatic, and (4) cerebral.
1. Endocrine. Vasomotor adrenergic factors were noted above; the endocrine adrenergic function of the adrenal medulla seems to be limited to the participation of pheochromocytoma in the genesis of hypertensive disease. Exclusion of hyperadrenalemia as a mechanism in essential hypertension suggests that there is little to be gained from further probing into adrenal medullary function in this disease. However, the stable hypertension which sometimes occurs while these tumors are in function and persists after their removal has not yet been adequately explained and remains as a provocative field of further study.
The adrenal cortex is the object of much more present concern than the medulla.'0 Desoxycorticosterone elicits in rats maintained on a high sodium diet both hypertension and hypertensive vascular disease. It is relatively, if not entirely, ineffective in this respect in dogs, but can provoke hypertension in some human beings, particularly those with pre-existing renal damage or loss of adrenal cortical function. It may not be a natural hormone of the adrenal cortex, but it is probable that the natural hormone functions in electrolyte metabolism in the same manner as does desoxycorticosterone. Consequently, experimental desoxycorticosterone hypertension is more than a pharmacologic tour de force. Indeed, Cushing's syndrome is an experiment by Nature which proves the participation of the adrenal cortex in hypertension and nephrosclerosis. The participation of the adrenal cortex as a genetic rather than merely sustaining mechanism of essential hypertension is quite unsolved. The fact that some patients respond to sodium restriction by a decrease of arterial pressure and amelioration of their disease has some analogy to what obtains in the desoxycorticosterone-treated rat. But their defect may be in the response of their tissues to a normal complement of hormone and/or electrolyte rather than to an excess of either substance. Indeed, the mechanism by which sodium excess or an increase in the sodium-potassium ratio of blood or tissues increases arterial pressure has not been analyzed. As concerns hypercorticoidism as a mechanism of essential hypertension, it can only be said that there are no substantial evidences of it, even in the sodiumresponsive patients. This is negative evidence and is based on methods which are admittedly crude. Some hypertensive patients do show abnormalities in the ratio of "free" (pH 1 extractable) to bound (glucuronide) corticoid in urine; more elaborate methods have demon-strated abnormalities in the pattern of 17ketosteroid excretion in a few patients.
The weight of evidence points away from hypercorticoidism and towards the possibility of a defect in tissue response. Recent preliminary evidence raises the possibility that one determinant of an abnormal response to the hormones of the adrenal cortex is growth hormone, which also elicits hypertension in rats. Clearly, the favorable responses of some few patients to t otal or subtotal adrenalectomy does not resolve the question. Rather the field is one in which speculation must soon be replaced by fact.
2. Renal. Mechanisms of renal hypertension are still very imperfectly understood. The most obvious is the renal pressor system; this consists of the enzyme renin, which acts on reniinsubstrate to release angiotonin; angiotonin is then disposed of by blood and tissue angiotonases. The assumption, once freely expressed, was that some abnormality of renal blood flow causes renin to be released and angiotonin to be formed in excess. However, the presence of excessive amounts of either substance in the blood of hypertensive patients or animals has not been proved by any direct means and most have come to the conclusion that, with the methods at hand, these substances cannot be shown to be regularly present in amounts which increase arterial pressure. Further, renal extracts containing renin have been slowly infused in animals and have not caused persistent hypertension; renal hypertension has persisted in animals made unresponsive to exogenous renin. These and other arguments have been advanced against the participation of the renal pressor system in renal hypertension. However, quite recently, prolonged hypertension has been obtained by the continuous infusion of renin in amounts so small that they would not have been found in blood by methods in current use, so that the question is still open.
Further, renin and angiotonin have other than pressor effects, since they induce diuresis, natriuresis and proteinuria. Renin-covitaimiing renal extracts in rats cause enlargement of the zona glomerulosa of the adrenal cortex, which is the presumed source of "mineralocorticoid" with the activity of desoxycorticosteronie and the same occurs in experimental renal hypertension. The subcutaneous injection of these renin-rich extracts in desoxycorticosterone-hypertensive rats elicits a condition which symptomatically resembles eclampsia, although its renal lesions resemble a violent malignant nephrosclerosis."1 Thus, there is some association of renal and adrenal mechanisms in experimental hypertension which remains to be studied in more detail. Other mechanisms may also participate. Thus, immunization of animals with renal extracts containing renin prevents the subsequent production of renal hypertension, some of the antisera thus obtained are depressors in animals with renal hypertension, and some of the extracts immunize also against vascular lesions.'2 Again, changes in vasomotor regulation, such as those which follow section of the sino-aortic buffer nerves, considerably alter and enhance responsiveness to renin and angiotonin.
Thus, participation of the renal pressor system in experimental renal hypertension is not proved, but remains as a reasonable hypothesis, although the action is possibly more complex than had been envisioned.13 The recent almost complete purification of renin points to the probability of a resolution of this problem.
The fact that renal hypertension occurs clinically and that it is humorally mediated stands uncontested, and it is a reasonable assumption that the progress of renal arteriolar sclerosis in essential hypertension adds the renal to the other mechanisms of this disease. The search for mediators of renal hypertension other than the renal pressor system has yielded the concept of the VEM-VD1\I system, in which ivasoexcitor material (VEM\) is a substance, not yet identified, but formed under appropriate conditions in the kidney.'4 VEM sensitizes the metarterioles (precapillary arterioles) to the action of adrenaline. Vasodepressor material (VDI1), identified as ferritin, inhibits this action. Possibly closely related to VE\I is pherentasin, an incompletely characterized pressor substance found in the blood of some patients with hypertension. Another substance of renal origin, the sustained pressor principle, has also been described and seems to be distinct from renin. Thus the humoral mechanism of renal hypertension is not identified and may be multiple, although to us the renal pressor system is the favored contender. The need for better understanding of these mechanisms and of their better integration with renal, adrenal and vasomotor influences is obvious.
3. Hepatic. Hepatic factors which may participate in hypertension are even more poorly defined than the renal. One substance, VDM, has been identified with ferritin or apoferritin. Renin-substrate is a globulin the hepatic formation of which seems in part to be conditioned by adrenal mineralocorticoid activity. Neither VDM nor renin-substrate seem likely as primary factors in the genesis of hypertensive disease. But there may be hepatic factors or functions which relate more directly to this condition. Thus, it is known that hepatectomized animals lose their vascular reactivity and succumb in circulatory collapse.15 The mechanism of this profound impairment of vascular reactivity is unexplained; the factors which underlie it may possibly bear on the problems of essential hypertension. But the field has yet to be explored. 4. Cerebral. The brain, inl common with other nervous tissue, (ontains the adrenergic compounds, adrenaline and noradrenaline. The relation of this adrenergic content to "encephalin, " a pressor substance present in extracts of cerebral tissue, has not been established, nor has the place of encephalin in cerebral or vascular function.16 Pitressin might be considered as having a place among cerebral pressor substances. However, it is very doubtful that it functions physiologically as anything more than an antidiuretic factor. The maximum release rate from the gland in man is of the order of 1 milliunit per minute, an amount which would not be pressor.
Quite recently a humorally transmitted vasoactive substance has been found to be released from within the cranium during stimulation of the central end of the cut vagus nerve.17 This material is not pitressin, nor is it adrenergic. Its demonstration suggests that the central nervous sytem may act as an endocrine organ in the control of arterial pressure. Since both substances are unidentified, the relationship of this cerebral pressor agent to another pressor substance found in ventricular fluid cannot be evaluated. Elucidation of this problem of humoral agents of cerebral origin is an attractive and, in viewof the psychic associations of essential hypertension, a tempting field of study.
In summary, the humoral mechanisms which bear on the problem of hypertension show a significant interrelationship between humoral and neural factors and among the humoral agents themselves.'8 Their study not only places great demands upon the chemists, but their interrelationships demand an extraordinary teamwork between chemists, physiologists and pharmacologists. Lastly, no note has been taken in this survey of the participation of depressor substances in the equilibria of humoral agents which determine normotension in healthy subjects, although the possibility exists that hypertenision results at times from a lack of the right depressor.
CONCLUSIONS
Knowledge of arterial hypertension has advanced rapidly during the past 20 years, so rapidly in fact that much current knowledge is only with great difficulty assimilated into a comprehensive schema. As happens so commonly, the problem has proved more difficult than was anticipated when the research began. Some of this difficulty and disappointment arise from the concept that essential hypertension has a unitary cause or a single mechanism. It is now apparent that progress will be made more rapidly and objectively by a recognition of the problem as one with many facets, in which neural and humoral factors can never operate alone, but only by the displacement of an equilibrium in which many mechanisms participate.
The urgent problem is the separation of essential hypertension as it occurs in patients into etiologic subgroups by objective means, so that appropriate, rational and effective treatment can be instituted. We see now through a glass darkly, but much less darkly and with much more hope than we (lid a few years ago.
Finally, the problem of essential hypertension is indissolubly mixed with that of hypertensive vasculai disease. Progress in the solution of the one w-ill have important connotations in the approach to the other. The resolution of both will lead to solution of the problem of perfusion of the tissues.
